Toxic epidermal necrolysis: does immunoglobulin make a difference?
about
Toxic epidermal necrolysis and Stevens-Johnson syndromeCytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsStevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.Skin Detachment and Regrowth in Toxic Epidermal NecrolysisStevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of ChinaCauses and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.Toxic epidermal necrolysis - management issues and treatment options.The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.Toxic epidermal necrolysis: current evidence, practical management and future directions.Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.The use of i.v. IG therapy in dermatology.Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?Toxic epidermal necrolysis from a cigarette burn.Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis.Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis.The management of toxic epidermal necrolysis.Clinical applications of immunoglobulin: update.Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies.Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.Continuous venovenous hemofiltration combined with hemoperfusion for toxic epidermal necrolysis: a retrospective cohort study.A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata.Treatments for Severe Cutaneous Adverse Reactions.SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.
P2860
Q21202877-D5D9F8E3-AECB-4FD6-BF87-D008B05BD229Q28395744-3DB33A5B-2F33-49D7-B5C1-26981DCE8D60Q33844415-90EA77A6-3D82-4E52-AA06-A3B06C015888Q34192104-D6EC93BC-9670-4644-8273-D090139715C7Q34225850-2C5A3195-89A2-4930-BE61-7F6C5A9B2545Q34416041-97DFAAAB-46CF-471A-87CE-42CE6F23011EQ34742870-F1211894-9673-4C16-9075-097CC3E68EC9Q36025252-70DBB19D-29DD-4E23-B92B-AD924E341425Q36154190-B35EBB68-EC09-450C-89E7-49E92926D1BDQ36208161-D7C97FCC-0C00-43F6-90C0-D5B5150E9104Q36222123-B5B04123-1B9D-4C62-B7A3-50E253A99B81Q36711702-14B25058-3297-49C8-B5C0-3BCF4A645FD2Q36986054-94349835-F34C-4BFC-ACF9-BF36A44E1E75Q37053492-10B6588E-9E2A-4353-A049-0E1BA9101385Q37786211-489CD4AE-1F3F-493F-9514-9FCD3559C2DAQ37802203-D520C4B8-5211-44AD-9A47-6A31E6F8E439Q37853599-946463C0-3335-4C35-B92F-1CBDB97C5B01Q37998131-215BCA13-D2C6-4C0C-9290-B02963A5F0F3Q38033613-E2C191BC-CB0D-4EED-A4F6-2C6F440CE195Q38050751-29154DD6-317D-40D2-9A04-27708E2EFEC1Q38123116-A2192EE4-FA7C-4AE1-A919-461EDB997772Q38201759-1B72AA46-709F-4BB7-9E95-EE6484E29211Q38235949-2E2212BD-D838-446A-BC05-BCF10ED889CBQ38766822-9F7C5F42-8D47-421F-9ECE-84CFBC32083BQ38851480-7B1DB046-2260-469D-8054-532FE5C539ABQ40083783-F0549018-B183-4D3B-B07F-D8A3EA3116EEQ40114511-C8FBEB09-D35B-4D06-8699-B2391FDBEE9FQ49264547-3A48D23C-E690-460D-B300-F20DDF50B7D7Q50115047-95D9321F-E449-4FD6-8855-FF62161073AF
P2860
Toxic epidermal necrolysis: does immunoglobulin make a difference?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@ast
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@en
type
label
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@ast
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@en
prefLabel
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@ast
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@en
P2093
P1476
Toxic epidermal necrolysis: does immunoglobulin make a difference?
@en
P2093
A Sandroni
G M Silver
P Walaszek
Richard L Gamelli
P356
10.1097/01.BCR.0000105096.93526.27
P577
2004-01-01T00:00:00Z